recombinant interferon alfa [clinicaltrials_resource:f81e2212aba7387a253442cf6cc521e8]
Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors [clinicaltrials:NCT00002470]Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002475]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer [clinicaltrials:NCT00002506]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002669]Biological Therapy in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002733]Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00002737]High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00002763]Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002767]Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer [clinicaltrials:NCT00002773]Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00002847]Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma [clinicaltrials:NCT00002892]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003027]Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer [clinicaltrials:NCT00003063]High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma [clinicaltrials:NCT00003091]Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003152]Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00003172]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin [clinicaltrials:NCT00003444]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer [clinicaltrials:NCT00003585]Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003639]Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00003656]Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically [clinicaltrials:NCT00003664]Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00003715]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003924]Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma [clinicaltrials:NCT00004039]Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy [clinicaltrials:NCT00004040]Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004063]Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00004104]BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer [clinicaltrials:NCT00004122]
intervention [clinicaltrials_vocabulary:intervention]
recombinant interferon alfa [clinicaltrials_resource:f81e2212aba7387a253442cf6cc521e8]
Bio2RDF identifier
f81e2212aba7387a253442cf6cc521e8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f81e2212aba7387a253442cf6cc521e8
intervention name [clinicaltrials_vocabulary:intervention-name]
recombinant interferon alfa
identifier
clinicaltrials_resource:f81e2212aba7387a253442cf6cc521e8
title
recombinant interferon alfa
@en
type
label
recombinant interferon alfa [clinicaltrials_resource:f81e2212aba7387a253442cf6cc521e8]
@en